Sunshine Lake Pharma Co., Ltd.

North & South Brother Pharmacy Investment Company Limited

Eaton Intelligent Power Limited

Murata Manufacturing Co., Ltd.

Nvidia Corporation

Schneider Electric It Corporation

Eaton Capital Unlimited Company

Xiaojun Wang

Yingjun Zhang

Xinye Yang

Jiancun Zhang

Liang Chen

Runfeng Lin

Shengtian Cao

Jun Xu

Yilei Gu

Junwen Wu

Changwei Huang

Yinglin Zuo

Chuanwen Yang

Jihua Lin

Shaohui Xiong

Shengqiang Pan

William James Dally

Yi Yu

Siegfried Goldmann

Qiang Li

Rui Guo

Birger Pahl

Yi Qin Yu

Jing Li

Jeffrey Michael Pool

Zheng Gu

Franciscus W Sijstermans

Ji Zhang

Zongyuan Zhang

Changchung Cheng

Bobby Leonard Compton

Wei-Hsiang Lin

Liang Wen

Yuefeng Shan

Wanjun Tang

Hong Chen

Pingjian Zhou

Yongshuai Bao

Facheng Ma

Qinjie Zheng

Zhou Yan

Yuanzhi Hua

Shoutao Wu

Xiaofeng Yuan

Jiancheng Wang

Zhaohe Wang

Chenlu Li

Zhifu Wan

Fangyuan Wu

Jingfeng Zhou

Ying Wang

Fei Wang

Jinquan Zhang

Shuhao Jiao

Dexue Fang

A crystalline form A of a nitrogen-containing tricyclic compound shown in formula (I), a pharmaceutical composition containing the crystalline form A, and the use of the crystalline form A or the pharmaceutical composition in the preparation of a medication for preventing, treating or relieving an FXR-mediated disease of a patient.

Crystalline form of nitrogen-containing tricyclic compound and use thereof

A power converter system including a DC bus, a DC/DC converter coupled to the DC bus, an inverter coupled to the DC bus and configured to convert DC power from the DC bus into output AC power having an output current, an output coupled to the inverter and configured to provide the output AC power to a load, and at least one controller configured to identify an impending high-load transient state at the output, and in response to identifying the impending high-load transient state, reduce a peak value of the output current of the output AC power by operating the DC/DC converter to reduce a voltage level on the DC bus and increasing a duty cycle of the inverter.

Inverter control strategy for a transient heavy load

A class of fluorine-substituted indazole compounds and uses thereof having the general formula depicted below in which C1 is where is the bond through which C1 is attached to L, and C2 is where is the bond through which C2 is attached to indazole, and pharmaceutical compositions containing these compounds. The compounds and pharmaceutical compositions of the invention can be used as soluble guanylate cyclase simulators.

Fluorine-substituted indazole compounds and uses thereof

Nitrogenous tricyclic compounds and uses thereof in medicine, in particular, a novel nitrogenous tricyclic compound used as an FXR active regulator and a stereoisomer, a geometrical isomer, a tautomer, a N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and use of the compound in the manufacture of a drug for treating a disease and/or disorder regulated by FXR. A pharmaceutically acceptable composition containing the compound and a method of treating a disease and/or disorder mediated by FXR comprising administering the compound or pharmaceutical composition thereof.

Nitrogenous tricyclic compounds and uses thereof in medicine

A primary coil can be inside the recess, where the primary coil is wound around the center of the recess. A secondary magnetic core can include a protruding center portion that is configured for insertion into the center of the recess so that the protruding center portion overlaps the primary magnetic core side wall and is configured to provide separation between the primary magnetic core and the secondary magnetic core. A secondary coil can be wound around the protruding center portion of the secondary magnetic core.

Wireless power transfer apparatus and power supplies including overlapping magnetic cores

A DC-to-DC converter includes at least one primary switch, a primary inductor, and a switch rectifier circuit or a switch flyback circuit. A switch driving circuit is structured to drive the at least one primary switch. A fault detection method includes directly or indirectly detecting a voltage waveform or a current waveform of at least one terminal of the primary inductor, and determining whether the at least one primary switch is in a diode rectifying state or in a diode flyback state based on the voltage waveform or the current waveform to detect whether there is a fault in the switch driving circuit.

Fault detection device and method for switch driving circuit, and electronic device

A method for preparing a pyrimidone compound and an important intermediate in which raw materials of the preparation method are cheap, the reaction condition of preparation method is mild, the preparation method is simple to operate, and is safe and controllable, has high total yield, and thus is suitable for industrial production.

Method for preparing pyrimidone compound

The present invention relates to a thienopyrimidine derivative and use thereof in medicine, and also to a pharmaceutical composition containing the compound. The compound or pharmaceutical composition is used for inhibiting acetyl-CoA carboxylase (ACC). The present invention also relates to a method of preparing such compound and pharmaceutical composition, as well as their use in the treatment or prevention of diseases regulated by acetyl-CoA carboxylase in mammals, especially in humans.

Thienopyrimidine derivative and use thereof in medicine

Provided are salts of 2,6-dimethylpyrimidone derivatives and uses thereof. Also provided are pharmaceutical compositions containing the salts.

Salts of 2,6-dimethylpyrimidone derivatives and uses thereof

A nitrogen-containing tricyclic compound which acts as modulator of FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the use of the compound for the treatment of disease and/or condition mediated by FXR are described. And a pharmaceutical composition containing the compound disclosed herein and a method of treatment of disease and/or condition mediated by FXR comprising administering the compound or the pharmaceutical composition thereof are also described.

Nitrogen-containing tricyclic compounds and uses thereof in medicine

The invention relates to capthepsin K inhibitors and uses thereof, specifically relates to a class of compounds having the formula (I) which are used for treating or preventing cathepsin dependent diseases or conditions, specifically, wherein the cathepsin is capthepsin K. The compounds and compositions thereof can be used as bone resorption inhibitors for the treatment of associated diseases. 

Cathepsin K inhibitors and application thereof

Carboxy-substituted (hetero)aryl derivatives, pharmaceutical compositions comprising these compounds, and methods of preparing such compounds and compositions are provided. The compounds or compositions are useful in inhibiting xanthine oxidase and urate anion transporter 1, and also can be used in the treatment or prevention of diseases associated with high blood uric acid level in mammals, especially humans.

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

The present invention relates to novel tricyclic compounds which can bind to FXR and act as modulators of the FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the uses of the compounds for the treatment of diseases and/or conditions mediated by FXR. The invention further provides a pharmaceutical composition containing the compound disclosed herein and a method of treatment of diseases and/or conditions mediated by FXR comprising administering the compound or the pharmaceutical composition.

Tricyclic compounds and uses thereof in medicine

An apparatus includes an enclosure and a coil assembly in the enclosure. The coil assembly includes a magnetic core and a coil disposed on the magnetic core. The magnetic core is positioned adjacent a wall of the enclosure such that a direction of a main flux path in the magnetic core is through at least one portion of the wall having a magnetic permeability greater than air. Such an arrangement may be used for a wireless power receiver unit configured to be installed in an equipment rack in data center applications.

Wireless power transfer apparatus using enclosures with enhanced magnetic features and methods of fabricating the same

A method, computer program product, and system for sparse convolutional neural networks that improves efficiency is described. Multi-bit data for input to a processing element is received at a compaction engine. The multi-bit data is determined to equal zero and a single bit signal is transmitted from the memory interface to the processing element in lieu of the multi-bit data, where the single bit signal indicates that the multi-bit data equals zero. A compacted data sequence for input to a processing element is received by a memory interface. The compacted data sequence is transmitted from the memory interface to an expansion engine. Non-zero values are extracted from the compacted data sequence and zeros are inserted between the non-zero values by the expansion engine to generate an expanded data sequence that is output to the processing element.

Data compaction and memory bandwidth reduction for sparse neural networks

Growing community of inventors

Dongguan, China

Xiaojun Wang